Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037893 · ClinicalTrials.gov registry record · Phase 2
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media
A Phase 2 study, sponsored by Currax Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 112
- Enrollment target
NCT02037893 is a Phase 2 study that has completed, run by Currax Pharmaceuticals. The registered enrollment target is 112 participants.
The verdict
NCT02037893, a Phase 2 study, has completed, sponsored by Currax Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 112 participants
- Enrollment target
Study Summary
The primary objective is to compare the effect of treatment with a combination of ear solutions on the reduction of pain symptoms at 1 hour after dosing in children with acute otitis media.
Interventions
- DRUG Benzocaine Otic Solution
- DRUG Antipyrine and Benzocaine otic solution
- DRUG Antipyrine Otic Solution
- DRUG Placebo Otic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02037893
The ClinicalTrials.gov registry entry for NCT02037893 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Currax Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Benzocaine Otic Solution is the first listed.
NCT02037893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02037893 about?
NCT02037893 is a clinical study titled "Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media". The primary objective is to compare the effect of treatment with a combination of ear solutions on the reduction of pain symptoms at 1 hour after dosing in children with acute otitis media.
What is the current status of trial NCT02037893?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 112 participants. The study started on 2013-11. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02037893?
The interventions under investigation include: Benzocaine Otic Solution (DRUG), Antipyrine and Benzocaine otic solution (DRUG), Antipyrine Otic Solution (DRUG), Placebo Otic solution (DRUG).
Who is sponsoring clinical trial NCT02037893?
This trial is sponsored by Currax Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.